Investor · Charlottesville, VA
Tony W. Goodman
Open Tony in the network graph →Filings
35
SEC Form D
Connections
112
co-filers
Capital
$21.7M
across filings
Active
Mar 2017
to Oct 2023
Most-connected co-filers (112)
James K. Anderson · Charlottesville, VA26 sharedJames W. Newman, Jr · Charlottesville, VA21 sharedKevin W. Schuyler, Cfa · Charlottesville, VA17 sharedCary J. Claiborne · Charlottesville, VA14 sharedRobertson H. Gilliland · Charlottesville, VA14 sharedDonald H. Kagin · Tiburon, CA14 sharedJoseph M. Truluck · Charlottesville, VA12 sharedFred Ausubel · Allston, MA11 sharedThomas G. Scriven · Golden, CO11 sharedKiran Bhatraju · WASHINGTON, Washington, D.C.11 sharedCory Brown · Nashville, TN11 sharedW. C. Mccollum · Los Angeles, CA11 sharedMike Kerns · Playa Vista, CA11 sharedJesse S. Jacobs · Playa Vista, CA11 sharedPeter Feld · New York, NY11 sharedMatthew Davis · Purcellville, VA11 sharedKweli Washington · New York, NY11 sharedWilliam B. Stilley, Iii · Charlottesville, VA10 sharedBankole A. Johnson · Charlottesville, VA10 sharedVinay J. Shah · Glen Allen, VA9 sharedJason Bergsman · SAN FRANCISCO, CA9 sharedLauren Smith · Nashville, TN9 sharedUrsula Newman · London, United Kingdom9 sharedSever Totia · Bethesda, MD9 shared
Recent filings (35)
EQT Real Estate Europe Living II (No.1) SCSpMar 2026 · 9 co-filersEQT Real Estate Europe Living II (No.2) SCSpMar 2026 · 9 co-filersADIAL PHARMACEUTICALS, INC.Dec 2025 · 20 co-filers$4.3MADIAL PHARMACEUTICALS, INC.Dec 2025 · 20 co-filers$4.3MEQT Exeter Europe Logistics Value Fund V (No.2) SCSpJun 2025 · 20 co-filersEQT Exeter Europe Logistics Value Fund V (No.1) SCSpJun 2025 · 20 co-filersADIAL PHARMACEUTICALS, INC.May 2025 · 20 co-filers$4.8MADIAL PHARMACEUTICALS, INC.May 2025 · 20 co-filers$4.8MCalidi Biotherapeutics, Inc.Jun 2024 · 23 co-filers$5.5MCalidi Biotherapeutics, Inc.Mar 2024 · 26 co-filers$341KCalidi Biotherapeutics, Inc.Mar 2024 · 26 co-filers$1.0MCalidi Biotherapeutics, Inc.Mar 2024 · 26 co-filers$10KCalidi Biotherapeutics, Inc.Mar 2024 · 26 co-filers$3.5MCalidi Biotherapeutics, Inc.Mar 2024 · 26 co-filers$65KADIAL PHARMACEUTICALS, INC.Mar 2024 · 15 co-filers$288KADIAL PHARMACEUTICALS, INC.Mar 2024 · 15 co-filers$288KADIAL PHARMACEUTICALS, INC.Oct 2023 · 23 co-filers$4.0MCalidi Biotherapeutics, Inc.Jun 2023 · 31 co-filers$25.0MADIAL PHARMACEUTICALS, INC.Jun 2023 · 26 co-filers$3.1MADIAL PHARMACEUTICALS, INC.Mar 2023 · 26 co-filers$62KColler GS Equity Pooling L.P.Jan 2023 · 14 co-filersFeeder HMC - US Partners (CIP IX), L.P.Jan 2023 · 14 co-filersFeeder HMC - US Partners (CCO I), L.P.Jan 2023 · 14 co-filersMaster PHC (CCO I), L.P.Jan 2023 · 14 co-filersMaster PHC (CIP IX), L.P.Jan 2023 · 14 co-filers
Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Tony in the interactive graph →